← Alle mensen

PA

P A Ascierto

11 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Gerandomiseerde, double-blind, phase III LEAP-003 study of eerstelijns lenvatinib plus pembrolizumab versus placebo p...
Annals of oncology : official journal of the European Society for Medical Oncology · 2025-12
Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology · 2025-10
Cutaan melanoom: ESMO 2025 richtlijn update
Annals of oncology : official journal of the European Society for Medical Oncology · 2025-01
Biomarkers bij atezolizumab-vemurafenib-cobimetinib bij BRAF-melanoom: IMspire150 analyse
Annals of oncology : official journal of the European Society for Medical Oncology · 2022-05
Locoregionaal melanoom: ESMO consensusaanbevelingen
Annals of oncology : official journal of the European Society for Medical Oncology · 2020-11
Gemetastaseerd melanoom: ESMO consensusaanbevelingen
Annals of oncology : official journal of the European Society for Medical Oncology · 2020-11
Baseline immuuninfiltraat en DFS bij adjuvant melanoom: prognostische impact
Annals of oncology : official journal of the European Society for Medical Oncology · 2020-01
Cutaan melanoom: ESMO 2019 richtlijn
Annals of oncology : official journal of the European Society for Medical Oncology · 1 december 2019
Vemurafenib bij BRAF V600-gemuteerd melanoom: definitieve totale overlevingsresultaten BRIM-3
Annals of oncology : official journal of the European Society for Medical Oncology · 1 oktober 2017
Incidentie, beloop en behandeling van toxiciteit bij cobimetinib-vemurafenib: coBRIM-studie
Annals of oncology : official journal of the European Society for Medical Oncology · 1 mei 2017
Effect van nivolumab op kwaliteit van leven bij niet eerder behandeld gevorderd melanoom: CheckMate 066
Annals of oncology : official journal of the European Society for Medical Oncology · 2016-10